Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Efficacy and Safety of Lamazym in Alpha-Mannosidosis
NCT01681940Phase 2Completed
- Sponsor
- Zymenex
- Start
- Jan 2012
- Primary completion
- Aug 2012
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
A Phase 2 trial of velmanase alfa in alpha-mannosidosis, sponsored by Zymenex. Started Jan 2012; status: completed.
02
Drugs
velmanase alfa
03
Conditions
alpha-mannosidosis
Beyond the preview
Go deeper on NCT01681940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01681940.